RANO criteria for response assessment of brain metastases based on amino acid PET imaging.

Saved in:
Bibliographic Details
Title: RANO criteria for response assessment of brain metastases based on amino acid PET imaging.
Authors: Albert NL; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany., Galldiks N; Department of Neurology, Faculty of Medicine, University Hospital Cologne, Cologne, Germany.; Institute of Neuroscience and Medicine (INM-3), Research Center Jülich, Jülich, Germany.; Center of Integrated Oncology Aachen Bonn Cologne Düsseldorf, Cologne, Germany., Ellingson BM; UCLA Brain Tumor Imaging Laboratory, Department of Radiological Sciences, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA., van den Bent MJ; The Brain Tumour Center at the Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Chang SM; Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA., Cicone F; Nuclear Medicine Unit, Department of Experimental and Clinical Medicine, 'Magna Græcia' University of Catanzaro, Catanzaro, Italy., Koh ES; Department of Radiation Oncology, Liverpool and Macarthur Cancer Therapy Centre, Liverpool, New South Wales, Australia.; South Western Sydney Clinical School, University of New South Wales, Sydney, New South Wales, Australia., Law I; Department of Clinical Physiology and Nuclear Medicine, Rigshospitalet, Copenhagen, Denmark., Le Rhun E; Department of Medical Oncology and Hematology, University Hospital and University of Zurich, Zurich, Switzerland., Mair MJ; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany.; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria., Werner JM; Department of Neurology, Faculty of Medicine, University Hospital Cologne, Cologne, Germany.; Institute of Neuroscience and Medicine (INM-3), Research Center Jülich, Jülich, Germany.; Center of Integrated Oncology Aachen Bonn Cologne Düsseldorf, Cologne, Germany.; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria., Berghoff AS; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria., Furtner J; Research Center for Medical Image Analysis and Artificial Intelligence, Faculty of Medicine and Dentistry, Danube Private University, Krems, Austria., Minniti G; Department of Radiological Sciences, Oncology and Anatomical Pathology, Sapienza University of Rome, Policlinico Umberto I, Rome, Italy.; IRCCS Neuromed, Pozzilli, Italy., Scott AM; Department of Molecular Imaging and Therapy, Austin Health and University of Melbourne, Melbourne, Victoria, Australia.; Olivia Newton-John Cancer Research Institute and School of Cancer Medicine, La Trobe University, Melbourne, Victoria, Australia., Short SC; Leeds Institute of Medical Research at St James's, the University of Leeds, Leeds, UK., Ivanidze J; Department of Radiology, Weill Cornell Medicine, New York, NY, USA., Johnson DR; Division of Nuclear Medicine, Department of Radiology, Mayo Clinic, Rochester, MN, USA., Suchorska B; Department of Neurosurgery, Heidelberg University Hospital, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany., Tolboom N; Department of Radiology and Nuclear Medicine, University Medical Center Utrecht, Utrecht, the Netherlands., Tonn JC; Department of Neurosurgery, LMU University Hospital, LMU Munich, Munich, Germany., Verger A; Department of Nuclear Medicine and Nancyclotep Imaging Platform, CHRU Nancy and IADI INSERM UMR 1254, Université de Lorraine, Nancy, France., Galanis E; Department of Oncology, Mayo Clinic, Rochester, MN, USA., Brastianos PK; Krantz Center for Cancer Research, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Wen PY; Center for Neuro-Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA., Weller M; Department of Neurology, University Hospital Zurich and University of Zurich, Zurich, Switzerland., Lin NU; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA., Preusser M; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria. matthias.preusser@meduniwien.ac.at.
Source: Nature medicine [Nat Med] 2025 May; Vol. 31 (5), pp. 1424-1430. Date of Electronic Publication: 2025 May 08.
Publication Type: Journal Article; Review
Journal Info: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1546-170X
DOI:10.1038/s41591-025-03633-7